Methyl (2R,3S)-2-(1,3-dioxolan-2-ylmethyl)-6-(2-ethylsulfanyl-2-oxoethyl)-3-methyloxane-2-carboxylate
C16H26O6S — CID 175984810
Data last refreshed: (MolForge compound catalog, from PubChem)
About Methyl (2R,3S)-2-(1,3-dioxolan-2-ylmethyl)-6-(2-ethylsulfanyl-2-oxoethyl)-3-methyloxane-2-carboxylate
Methyl (2R,3S)-2-(1,3-dioxolan-2-ylmethyl)-6-(2-ethylsulfanyl-2-oxoethyl)-3-methyloxane-2-carboxylate (PubChem CID 175984810) has the molecular formula C16H26O6S and a molecular weight of 346.45 g/mol. Its IUPAC name is methyl (2R,3S)-2-(1,3-dioxolan-2-ylmethyl)-6-(2-ethylsulfanyl-2-oxoethyl)-3-methyloxane-2-carboxylate.
Molecular Properties
| Compound Name | Methyl (2R,3S)-2-(1,3-dioxolan-2-ylmethyl)-6-(2-ethylsulfanyl-2-oxoethyl)-3-methyloxane-2-carboxylate |
|---|---|
| PubChem CID | 175984810 |
| Molecular Formula | C16H26O6S |
| Molecular Weight | 346.45 g/mol |
| Exact Mass | 346.15 |
| IUPAC Name | methyl (2R,3S)-2-(1,3-dioxolan-2-ylmethyl)-6-(2-ethylsulfanyl-2-oxoethyl)-3-methyloxane-2-carboxylate |
| SMILES | CCSC(=O)CC1CC[C@H](C)[C@](CC2OCCO2)(C(=O)OC)O1 |
| InChI | InChI=1S/C16H26O6S/c1-4-23-13(17)9-12-6-5-11(2)16(22-12,15(18)19-3)10-14-20-7-8-21-14/h11-12,14H,4-10H2,1-3H3/t11-,12?,16+/m0/s1 |
| InChIKey | IWCQUAQCCCQZSC-QRUKAPELSA-N |
| XLogP | 2.15 |
| TPSA | 71.06 Ų |
| H-Bond Donors | |
| H-Bond Acceptors | 7 |
| Rotatable Bonds | 6 |
| Heavy Atoms | 23 |
| Complexity | — |
Lipinski Rule of Five
Passes Rule of Five
| Rule | Value |
|---|---|
| MW ≤ 500 | 346.45 |
| LogP ≤ 5 | 2.15 |
| H-Bond Donors ≤ 5 | 0 |
| H-Bond Acceptors ≤ 10 | 7 |
Computed Properties (RDKit)
| Structural Alerts | {'alert_name': 'thioester', 'substructure': 'N/A'} |
|---|
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 175984810 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.